Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy

Anan, 2007, Mutations in the genes for sarcomeric proteins in Japanese patients with onset sporadic hypertrophic cardiomyopathy after age 40 years, Am. J. Cardiol., 99, 1750, 10.1016/j.amjcard.2007.01.066 Andrews, 1999, Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA, Nat. Genet., 23, 147, 10.1038/13779 Bagnall, 2010, Analysis of the Z-disc genes PDLIM3 and MYPN in patients with hypertrophic cardiomyopathy, Int. J. Cardiol., 145, 601, 10.1016/j.ijcard.2010.08.004 Bahrudin, 2008, Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy, J. Mol. Biol., 384, 896, 10.1016/j.jmb.2008.09.070 Bates, 2012, Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management, Eur. Heart J., 33, 3023, 10.1093/eurheartj/ehs275 Biagini, 2009, Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy, Am. J. Cardiol., 104, 1727, 10.1016/j.amjcard.2009.07.057 Bick, 2012, Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts, Am. J. Hum. Genet., 91, 513, 10.1016/j.ajhg.2012.07.017 Brandon, 2005, MITOMAP: a human mitochondrial genome database–2004 update, Nucleic Acids Res., 33, D611, 10.1093/nar/gki079 Castro, 2006, Mitochondrial DNA haplogroups in Spanish patients with hypertrophic cardiomyopathy, Int. J. Cardiol., 112, 202, 10.1016/j.ijcard.2005.09.008 Chaitanya, 2015, Simultaneous whole mitochondrial genome sequencing with short overlapping amplicons suitable for degraded DNA using the ion torrent personal genome machine, Hum. Mutat., 36, 1236, 10.1002/humu.22905 Chikamori, 1992, Comparison of clinical, morphological, and prognostic features in hypertrophic cardiomyopathy between Japanese and western patients, Clin. Cardiol., 15, 833, 10.1002/clc.4960151108 Chinnery, 1997, Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes, Brain: J. Neurol., 120, 1713, 10.1093/brain/120.10.1713 Chinnery, 2013, Mitochondrial genetics, Br. Med. Bull., 106, 135, 10.1093/bmb/ldt017 Choi, 2008, Phenotypic spectrum and clinical characteristics of apical hypertrophic cardiomyopathy: multicenter echo-Doppler study, Cardiology, 110, 53, 10.1159/000109407 Christiansen, 2015, Mitochondrial haplogroups are associated with hypertrophic cardiomyopathy in the Indian population, Mitochondrion, 20, 105, 10.1016/j.mito.2014.07.010 Chung, 2019, Genetic relevance and determinants of mitral leaflet size in hypertrophic cardiomyopathy, Cardiovasc. Ultrasound, 17, 21, 10.1186/s12947-019-0171-1 Coppini, 2014, Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations, J. Am. Coll. Cardiol., 64, 2589, 10.1016/j.jacc.2014.09.059 Dass, 2015, Exacerbation of cardiac energetic impairment during exercise in hypertrophic cardiomyopathy: a potential mechanism for diastolic dysfunction, Eur. Heart J., 36, 1547, 10.1093/eurheartj/ehv120 Davidson, 2009, Evidence for nuclear modifier gene in mitochondrial cardiomyopathy, J. Mol. Cell. Cardiol., 46, 936, 10.1016/j.yjmcc.2009.02.011 Eriksson, 2002, Long-term outcome in patients with apical hypertrophic cardiomyopathy, J. Am. Coll. Cardiol., 39, 638, 10.1016/S0735-1097(01)01778-8 Ghezzi, 2018, Human diseases associated with defects in assembly of OXPHOS complexes, Essays Biochem., 62, 271, 10.1042/EBC20170099 Gruner, 2011, Sarcomere protein gene mutations in patients with apical hypertrophic cardiomyopathy. Circulation, Cardiovasc. Genet., 4, 288, 10.1161/CIRCGENETICS.110.958835 Ho, 2018, Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe), Circulation, 138, 1387, 10.1161/CIRCULATIONAHA.117.033200 Ho, 2017, The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study, JAMA Cardiol., 2, 419, 10.1001/jamacardio.2016.5670 Ingman, 2006, mtDB: Human Mitochondrial Genome Database, a resource for population genetics and medical sciences, Nucleic Acids Res., 34, D749, 10.1093/nar/gkj010 Ionita-Laza, 2013, Sequence kernel association tests for the combined effect of rare and common variants, Am. J. Hum. Genet., 92, 841, 10.1016/j.ajhg.2013.04.015 Kitaoka, 2003, Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States, Am. J. Cardiol., 92, 1183, 10.1016/j.amjcard.2003.07.027 Kraja, 2019, Associations of Mitochondrial and Nuclear Mitochondrial Variants and Genes with Seven Metabolic Traits, Am. J. Hum. Genet., 104, 112, 10.1016/j.ajhg.2018.12.001 Lee, 2014, Rare-variant association analysis: study designs and statistical tests, Am. J. Hum. Genet., 95, 5, 10.1016/j.ajhg.2014.06.009 Li, 2009, Fast and accurate short read alignment with Burrows-Wheeler transform, Bioinformatics (Oxford, England), 25, 1754, 10.1093/bioinformatics/btp324 Li, 2010, A survey of sequence alignment algorithms for next-generation sequencing, Briefings Bioinf., 11, 473, 10.1093/bib/bbq015 Li, 2018, Mitochondrial Dysfunctions Contribute to Hypertrophic Cardiomyopathy in Patient iPSC-Derived Cardiomyocytes with MT-RNR2 Mutation, Stem Cell Rep., 10, 808, 10.1016/j.stemcr.2018.01.013 Lin, 1996, Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy, J. Clin. Investig., 97, 2842, 10.1172/JCI118740 Maron, 2002, Hypertrophic cardiomyopathy: a systematic review, JAMA, 287, 1308, 10.1001/jama.287.10.1308 Maron, 2012, Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives, J. Am. Coll. Cardiol., 60, 705, 10.1016/j.jacc.2012.02.068 McKenna, 2010, The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data, Genome Res., 20, 1297, 10.1101/gr.107524.110 Miller, 2001, Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation, J. Biol. Chem., 276, 3743, 10.1074/jbc.M006746200 Moon, 2011, Clinical and echocardiographic predictors of outcomes in patients with apical hypertrophic cardiomyopathy, Am. J. Cardiol., 108, 1614, 10.1016/j.amjcard.2011.07.024 Nagueh, 2016, Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, J. Am. Soc. Echocardiogr. : Off. Publ. Am. Soc. Echocardiogr., 29, 277, 10.1016/j.echo.2016.01.011 Poyton, 1996, Crosstalk between nuclear and mitochondrial genomes, Annu. Rev. Biochem., 65, 563, 10.1146/annurev.bi.65.070196.003023 Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W.W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., Rehm, H.L., 2015. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. 17, pp. 405–424. Sedaghat-Hamedani, F., Kayvanpour, E., Tugrul, O.F., Lai, A., Amr, A., Haas, J., Proctor, T., Ehlermann, P., Jensen, K., Katus, H.A., Meder, B., 2018. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals. 107, pp. 30–41. Seidman, 2011, Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history, Circ. Res., 108, 743, 10.1161/CIRCRESAHA.110.223834 Strauss, 2013, Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup, PNAS, 110, 3453, 10.1073/pnas.1300690110 Tardiff, 2005, Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes, Heart Fail. Rev., 10, 237, 10.1007/s10741-005-5253-5 Towe, 2015, Genotype-Phenotype Correlations in Apical Variant Hypertrophic Cardiomyopathy, Congenital Heart Dis., 10, E139, 10.1111/chd.12242 van Velzen, H.G., Schinkel, A.F.L., Oldenburg, R.A., van Slegtenhorst, M.A., Frohn-Mulder, I.M.E., van der Velden, J., Michels, M., 2017. Clinical Characteristics and Long-Term Outcome of Hypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding Protein C) Founder Mutation. Circulation. Cardiovascular genetics 10. Wang, 2008, Strikingly different penetrance of LHON in two Chinese families with primary mutation G11778A is independent of mtDNA haplogroup background and secondary mutation G13708A, Mutat. Res., 643, 48, 10.1016/j.mrfmmm.2008.06.004 Wang, 2010, ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data, Nucleic Acids Res., 38, 10.1093/nar/gkq603 Wessels, 2015, Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects, Eur. J. Human Genetics: EJHG, 23, 922, 10.1038/ejhg.2014.211 Whiffin, 2017, Using high-resolution variant frequencies to empower clinical genome interpretation, Genet. Med.: Off. J. Am. Coll. Med. Genet., 19, 1151, 10.1038/gim.2017.26 Whiffin, 2018, CardioClassifier: disease- and gene-specific computational decision support for clinical genome interpretation, Genet. Med.: Off. J. Am. Coll. Med. Genet., 20, 1246, 10.1038/gim.2017.258 Wu, 2015, Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing, J. Am. Heart Assoc., 4, 10.1161/JAHA.115.001879 Yang, 2015, SAMSVM: A tool for misalignment filtration of SAM-format sequences with support vector machine, J. Bioinf. Comput. Biol., 13, 1550025, 10.1142/S0219720015500250 Zaragoza, 2011, Mitochondrial cardiomyopathies: how to identify candidate pathogenic mutations by mitochondrial DNA sequencing, MITOMASTER and phylogeny, Eur. J. Human Genet.: EJHG, 19, 200, 10.1038/ejhg.2010.169